-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – B-244 in Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - B-244 in Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. B-244 in Hypertension Drug Details: B-244 is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – B-244 in Migraine
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - B-244 in Migraine report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. B-244 in Migraine Drug Details: B-244 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ICTCAR-028 in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ICTCAR-028 in Esophageal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ICTCAR-028 in Esophageal Cancer Drug Details: ICTCAR-028 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – B-244 in Seasonal Allergic Rhinitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - B-244 in Seasonal Allergic Rhinitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. B-244 in Seasonal Allergic Rhinitis Drug Details: B-244 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – B-244 in Atopic Dermatitis (Atopic Eczema)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - B-244 in Atopic Dermatitis (Atopic Eczema) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. B-244 in Atopic Dermatitis (Atopic Eczema) Drug Details: B-244 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Zanubrutinib in Kidney Disease (Nephropathy)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Zanubrutinib in Kidney Disease (Nephropathy) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Zanubrutinib in Kidney Disease (Nephropathy) Drug Details: Zanubrutinib (Brukinsa) acts...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ixazomib Citrate in Kidney Cancer (Renal Cell Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ixazomib Citrate in Kidney Cancer (Renal Cell Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ixazomib Citrate in Kidney Cancer (Renal Cell Cancer)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Nacubactam in Pyelonephritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nacubactam in Pyelonephritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nacubactam in Pyelonephritis Drug Details: Nacubactam (RG6080, RO7079901) is under development for the...
-
Product Insights
Rosacea – Drugs In Development, 2023
Global Markets Direct’s, ‘Rosacea - Drugs In Development, 2023’, provides an overview of the Rosacea pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rosacea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Seasonal Allergic Rhinitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Seasonal Allergic Rhinitis - Drugs In Development, 2023’, provides an overview of the Seasonal Allergic Rhinitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Seasonal Allergic Rhinitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...